CA2237647A1 - Processes and intermediates for preparing 1-benzyl-4-((5,6-dimethoxy-1-indanon)-2-yl)methylpiperidine - Google Patents

Processes and intermediates for preparing 1-benzyl-4-((5,6-dimethoxy-1-indanon)-2-yl)methylpiperidine Download PDF

Info

Publication number
CA2237647A1
CA2237647A1 CA002237647A CA2237647A CA2237647A1 CA 2237647 A1 CA2237647 A1 CA 2237647A1 CA 002237647 A CA002237647 A CA 002237647A CA 2237647 A CA2237647 A CA 2237647A CA 2237647 A1 CA2237647 A1 CA 2237647A1
Authority
CA
Canada
Prior art keywords
alkyl
compound
formula
halo
trifluoromethyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002237647A
Other languages
English (en)
French (fr)
Inventor
Keith M. Devries
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Inc
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2237647A1 publication Critical patent/CA2237647A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/30Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by doubly bound oxygen or sulfur atoms or by two oxygen or sulfur atoms singly bound to the same carbon atom
    • C07D211/32Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by doubly bound oxygen or sulfur atoms or by two oxygen or sulfur atoms singly bound to the same carbon atom by oxygen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
CA002237647A 1995-12-15 1996-10-11 Processes and intermediates for preparing 1-benzyl-4-((5,6-dimethoxy-1-indanon)-2-yl)methylpiperidine Abandoned CA2237647A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US875395P 1995-12-15 1995-12-15
US60/008,753 1995-12-15
PCT/IB1996/001076 WO1997022584A1 (en) 1995-12-15 1996-10-11 Processes and intermediates for preparing 1-benzyl-4-((5,6-dimethoxy-1-indanon)-2-yl)methylpiperidine

Publications (1)

Publication Number Publication Date
CA2237647A1 true CA2237647A1 (en) 1997-06-26

Family

ID=21733469

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002237647A Abandoned CA2237647A1 (en) 1995-12-15 1996-10-11 Processes and intermediates for preparing 1-benzyl-4-((5,6-dimethoxy-1-indanon)-2-yl)methylpiperidine

Country Status (33)

Country Link
EP (1) EP0883607A1 (ja)
JP (1) JP3066083B2 (ja)
KR (1) KR20000064387A (ja)
AP (1) AP708A (ja)
AR (1) AR004368A1 (ja)
AU (1) AU716462B2 (ja)
BG (1) BG102525A (ja)
BR (1) BR9612018A (ja)
CA (1) CA2237647A1 (ja)
CO (1) CO4750831A1 (ja)
CZ (1) CZ180898A3 (ja)
DZ (1) DZ2141A1 (ja)
GT (1) GT199600092A (ja)
HN (1) HN1996000065A (ja)
HR (1) HRP960592A2 (ja)
HU (1) HUP9904275A3 (ja)
IL (3) IL136421A0 (ja)
IS (1) IS4752A (ja)
MA (1) MA24032A1 (ja)
NO (1) NO982712L (ja)
NZ (1) NZ318843A (ja)
OA (1) OA10694A (ja)
PE (1) PE25698A1 (ja)
PL (1) PL197306B1 (ja)
RO (1) RO121382B1 (ja)
RU (1) RU2160731C2 (ja)
SK (1) SK75498A3 (ja)
TN (1) TNSN96153A1 (ja)
TW (1) TW414787B (ja)
UY (1) UY24401A1 (ja)
WO (1) WO1997022584A1 (ja)
YU (1) YU49486B (ja)
ZA (1) ZA9610533B (ja)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999036405A1 (en) 1998-01-16 1999-07-22 Eisai Co., Ltd. Process for production of donepezil derivative
IL125809A (en) * 1998-08-17 2005-08-31 Finetech Lab Ltd Process and intermediates for production of donepezil and related compounds
US7148354B2 (en) * 2002-07-24 2006-12-12 Dr. Reddy's Laboratories Limited Process for preparation of donepezil
IL150982A (en) 2002-07-30 2007-02-11 Ori Lerman Process for making Donafzil
IL151253A0 (en) * 2002-08-14 2003-04-10 Finetech Lab Ltd Process for production of highly pure donepezil hydrochloride
US6953856B2 (en) 2003-02-12 2005-10-11 Usv, Limited Process for the preparation of 1-benzyl-4-(5,6-dimethoxy-1-indanon)-2-yl) methyl piperidine hydrochloride (Donepezil HCI)
US6649765B1 (en) 2003-02-12 2003-11-18 Usv Limited, Bsd Marg. Process for the preparation of 1-benzyl-4(5,6-dimethoxy-1-indanon)-2-yl) methyl piperidine hydrochloride (Donepezil HCL)
US20070129549A1 (en) * 2003-03-21 2007-06-07 Yatendra Kumar Stable lamotrigine pharmaceutical compositions and processes for their preparation
WO2004099142A1 (en) * 2003-05-05 2004-11-18 Ranbaxy Laboratories Limited Hydrobromide salt of benzyl-piperidylmethyl-indanone and its polymorphs
AU2003247158A1 (en) 2003-07-01 2005-01-21 Hetero Drugs Limited Preparation of intermediates for acetyl cholinesterase inhibitors
CN1280273C (zh) * 2003-11-05 2006-10-18 天津和美生物技术有限公司 合成多奈哌齐及其衍生物的方法
WO2006035433A2 (en) 2004-09-29 2006-04-06 Chemagis Ltd. Use of purified donepezil maleate for preparing pharmaceutically pure amorphous donepezil hydrochloride
CN100436416C (zh) * 2005-07-29 2008-11-26 西南合成制药股份有限公司 盐酸多奈哌齐合成工艺
GB0515803D0 (en) 2005-07-30 2005-09-07 Pliva Hrvatska D O O Intermediate compounds
AR057910A1 (es) 2005-11-18 2007-12-26 Synthon Bv Proceso para preparar donepezilo
ES2354737T3 (es) * 2006-01-04 2011-03-17 Cipla Limited Procedimiento y producto intermedio para la preparación de donepezylo.
CN101626688A (zh) 2006-12-11 2010-01-13 雷维瓦药品公司 茚满酮基胆碱酯酶抑制剂的组合物、合成和使用方法
WO2013078608A1 (en) 2011-11-29 2013-06-06 Ziqiang Gu Donepezil pamoate and methods of making and using the same
US10357486B2 (en) 2013-08-16 2019-07-23 Universiteit Maastricht Treatment of cognitive impairment with PDE4 inhibitor

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI95572C (fi) * 1987-06-22 1996-02-26 Eisai Co Ltd Menetelmä lääkeaineena käyttökelpoisen piperidiinijohdannaisten tai sen farmaseuttisen suolan valmistamiseksi
FR2642069B1 (fr) * 1989-01-20 1991-04-12 Rhone Poulenc Sante Nouveaux derives du benzopyranne, leur preparation et les compositions pharmaceutiques qui les contiennent
DE4439822A1 (de) * 1994-11-08 1996-08-29 Bayer Ag Verfahren zur Herstellung von Benzyl-piperidylmethyl-indanonen

Also Published As

Publication number Publication date
IS4752A (is) 1998-05-22
TNSN96153A1 (fr) 2005-03-15
IL124452A0 (en) 1998-12-06
JP3066083B2 (ja) 2000-07-17
CZ180898A3 (cs) 1999-05-12
IL136420A0 (en) 2001-06-14
AR004368A1 (es) 1998-11-04
NO982712D0 (no) 1998-06-12
AP9600892A0 (en) 1997-01-31
MX9804820A (es) 1998-10-31
MA24032A1 (fr) 1997-07-01
HRP960592A2 (en) 1998-06-30
CO4750831A1 (es) 1999-03-31
NZ318843A (en) 2000-01-28
IL136421A0 (en) 2001-06-14
ZA9610533B (en) 1998-06-15
HN1996000065A (es) 1997-06-26
PL197306B1 (pl) 2008-03-31
PL327512A1 (en) 1998-12-21
KR20000064387A (ko) 2000-11-06
HUP9904275A3 (en) 2001-05-28
HUP9904275A2 (hu) 2000-05-28
YU49486B (sh) 2006-08-17
AP708A (en) 1998-12-04
AU7092596A (en) 1997-07-14
PE25698A1 (es) 1998-05-21
RU2160731C2 (ru) 2000-12-20
NO982712L (no) 1998-06-12
RO121382B1 (ro) 2007-04-30
WO1997022584A1 (en) 1997-06-26
GT199600092A (es) 1998-05-12
DZ2141A1 (fr) 2002-07-23
BG102525A (en) 1999-05-31
UY24401A1 (es) 1997-06-09
TW414787B (en) 2000-12-11
BR9612018A (pt) 1999-02-17
YU66096A (en) 1999-11-22
EP0883607A1 (en) 1998-12-16
SK75498A3 (en) 1999-08-06
JPH11500756A (ja) 1999-01-19
OA10694A (en) 2001-05-04
AU716462B2 (en) 2000-02-24

Similar Documents

Publication Publication Date Title
CA2237647A1 (en) Processes and intermediates for preparing 1-benzyl-4-((5,6-dimethoxy-1-indanon)-2-yl)methylpiperidine
JP4754494B2 (ja) N−[フェニル(アルキルピペリジン−2−イル)メチル]ベンズアミド誘導体、この調製方法およびこの治療法における使用
US7951821B2 (en) N-[phenyl(piperidin-2-yl)methyl]benzamide derivatives, preparation thereof, and use thereof in therapy
JP2007508359A (ja) N−[ヘテロアリル(ピペリジン−2−イル)メチル]ベンズアミドの誘導体、この調製方法およびこの治療法における使用
US20100174085A1 (en) crystalline polymorphic forms of fexofenadine
CA2629720A1 (en) Synthesis and preparations of intermediates and polymorphs thereof useful for the preparation of donepezil hydrochloride
JP3433752B2 (ja) ピペリジン誘導体およびその誘導体を有効成分とする薬剤
EP2261209A1 (en) Novel crystalline forms of 4-[4-[4- hydroxydiphenylmethyl)-1-piperidinyl]-1-hydroxybutyl]-alpha, alpha-dimethylbenene acetic acid and its hydrochloride
EP0342635A1 (en) Azacyclic carboxylic acid derivatives, their preparation and use
AU2001278094A1 (en) Novel crystalline forms of 4-[4-[4-(hydroxydiphenylmethyl)-1-piperindinyl]-1-hydroxybutyl]-alpha, alpha-dimethylbenzene acetic acid and its hydrochloride
AU2003248428B2 (en) Process for the preparation of enantiomerically pure N-methyl-N-[(1S)-phenyl-2-((3S)-3-hydroxypyrrolidin-1-yl)ethyl]-2,2-diphenylacetamide
JP2003509494A (ja) ムスカリン拮抗薬
JP2002506059A (ja) (R)−α−(2,3−ジメトキシフェニル)−1−[2−(4−フルオロフェニル)エチル]−4−ピペリジンメタノールの製造方法
EP3794001B1 (en) Intermediates and processes for the preparation of linagliptin and its salts
US6803468B2 (en) Process for the synthesis of n-(5-methylnicontinoyl)-4 hydroxypiperidine, a key intermediate of rupatadine
CZ280931B6 (cs) Opticky aktivní karboxamidové deriváty, farmaceutický prostředek s analgetickým účinkem a prostředek s agonistickým účinkem vzhledem ke k-receptorům
MXPA98004820A (en) Procedures and intermediates for preparing 1-bencil-4 - ((5,6-dimetoxi-1-indanon) -2-il) metilpiperid
Brine et al. Synthesis of 4, 4‐disubstituted piperidine analogs of (±)‐cis‐N‐[1‐(2‐hydroxy‐2‐phenylethyl)‐3‐methyl‐4‐piperidyl]‐N‐phenylpropanamide
SA96170395B1 (ar) عمليات ومركبات وسطية لتحضير 1- بنزيل - 4 - ((5.6-ثنائي ميثوكسي -1- إندانون) -2- يل) ميثيل بيبريدين 1-benzy1-4-((5.6-dimethoxy -1-Indanon)-2-y1)methy1piperidine
WO2001002357A2 (en) Process for the synthesis of 4-(4'-fluorophenyl)-piperidines
CS205086B2 (cs) Způsob výroby hydroxyderivátů aryloxy- a arylthioperhydroazaheterocyklů
MXPA06004274A (en) Derivatives of n-[phenyl(alkylpiperidine-2-yl)methyl]benzamide, preparation method thereof and application of same in therapeutics
KR20020042619A (ko) 황산모노-[3-({1-[2-(4-플루오로-페닐)-에틸]-피페리딘-4-일}-하이드록시-메틸)-2-메톡시-페닐]에스테르
KR20050122481A (ko) 암로디핀 베실레이트염의 신규한 중간체 화합물 및 이를이용한 암로디핀 베실레이트염의 제조 방법

Legal Events

Date Code Title Description
EEER Examination request
FZDE Discontinued